Reduction of Immunosuppression as Initial Therapy for Post-Transplantation Lymphoproliferative Disorder

Reduction of immunosuppression (RI) is commonly used to treat post-transplant lymphoproliferative disorder (PTLD) in solid organ transplant recipients. We investigated the efficacy, safety and predictors of response to RI in adult patients with PTLD. 67 patients were managed with RI alone and 30 pat...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Reshef, R, Vardhanabhuti, S, Luskin, MR, Heitjan, DF, Hadjiliadis, D, Goral, S, Krok, KL, Goldberg, LR, Porter, DL, Stadtmauer, EA, Tsai, DE
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2011
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3079420/
https://ncbi.nlm.nih.gov/pubmed/21219573
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1600-6143.2010.03387.x
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk